Rosacea, Erythematotelangiectatic
6 clinical trials · Condition
◉ Watch Rosacea, Erythematotelangiectatic
| Record | Firm | Date |
|---|---|---|
| Topical Mitogenic-Activated Protein Kinase (MAPK) Inhibition in Rosacea (NCT05616923) | Albany Research Institute, Inc. | 2021-11-01 |
Track Rosacea, Erythematotelangiectatic automatically
Every clearance here is in the API, with alerts when new ones post.